ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 228 filers reported holding ACADIA PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 0.98 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $925 | -16.0% | 44,400 | -3.5% | 0.00% | -20.0% |
| Q2 2023 | $1,101 | -39.5% | 46,000 | -52.5% | 0.01% | +66.7% |
| Q1 2023 | $1,820 | +98.7% | 96,800 | +68.1% | 0.00% | -25.0% |
| Q4 2022 | $916 | -99.9% | 57,600 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $942,000 | -0.4% | 57,600 | -14.3% | 0.00% | 0.0% |
| Q2 2022 | $946,000 | -29.2% | 67,200 | +21.7% | 0.00% | -20.0% |
| Q1 2022 | $1,336,000 | +0.8% | 55,200 | -2.8% | 0.01% | 0.0% |
| Q4 2021 | $1,325,000 | +13.5% | 56,800 | -19.2% | 0.01% | +25.0% |
| Q3 2021 | $1,167,000 | -14.4% | 70,300 | +25.8% | 0.00% | -20.0% |
| Q2 2021 | $1,363,000 | +101.3% | 55,900 | +300.2% | 0.01% | +66.7% |
| Q2 2020 | $677,000 | -59.2% | 13,968 | -64.5% | 0.00% | -66.7% |
| Q1 2020 | $1,660,000 | -5.6% | 39,300 | -4.4% | 0.01% | +28.6% |
| Q4 2019 | $1,758,000 | -39.4% | 41,100 | -49.0% | 0.01% | +16.7% |
| Q3 2019 | $2,900,000 | +124.6% | 80,600 | +66.9% | 0.01% | 0.0% |
| Q2 2019 | $1,291,000 | -5.7% | 48,300 | -5.3% | 0.01% | 0.0% |
| Q1 2019 | $1,369,000 | +825.0% | 51,000 | +862.3% | 0.01% | +500.0% |
| Q1 2016 | $148,000 | -59.2% | 5,300 | -48.0% | 0.00% | -50.0% |
| Q4 2015 | $363,000 | -7.6% | 10,200 | -14.3% | 0.00% | 0.0% |
| Q3 2015 | $393,000 | -52.8% | 11,900 | -40.2% | 0.00% | -50.0% |
| Q2 2015 | $833,000 | +181.4% | 19,900 | +118.7% | 0.00% | +300.0% |
| Q1 2015 | $296,000 | +15.2% | 9,100 | +12.3% | 0.00% | 0.0% |
| Q4 2014 | $257,000 | +99.2% | 8,100 | +55.8% | 0.00% | – |
| Q3 2014 | $129,000 | +460.9% | 5,200 | +420.0% | 0.00% | – |
| Q2 2014 | $23,000 | -91.7% | 1,000 | -91.2% | 0.00% | -100.0% |
| Q1 2014 | $277,000 | +163.8% | 11,400 | +171.4% | 0.00% | – |
| Q4 2013 | $105,000 | -82.0% | 4,200 | -80.2% | 0.00% | -100.0% |
| Q3 2013 | $584,000 | +722.5% | 21,246 | +444.8% | 0.00% | – |
| Q2 2013 | $71,000 | – | 3,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 563,200 | $16,243,000 | 9.48% |
| Avoro Capital Advisors LLC | 1,486,460 | $42,870,000 | 8.66% |
| Baker Brothers Advisors | 25,819,768 | $744,642,000 | 7.30% |
| SECTORAL ASSET MANAGEMENT INC | 1,176,543 | $33,932,000 | 3.76% |
| HARVEY CAPITAL MANAGEMENT INC | 251,825 | $7,262,000 | 3.38% |
| ACUTA CAPITAL PARTNERS, LLC | 300,000 | $8,652,000 | 3.22% |
| Palo Alto Investors LP | 1,532,030 | $44,184,000 | 2.52% |
| Ghost Tree Capital, LLC | 350,000 | $10,094,000 | 2.43% |
| EMORY UNIVERSITY | 76,121 | $2,195,000 | 2.16% |
| WEATHERBIE CAPITAL, LLC | 576,784 | $16,634,000 | 2.09% |